The short answer: the interventions that lower a biological age reading are the same ones that lower your risk of dying, and they are unglamorous. Stop smoking. Fix insulin resistance. Lose visceral fat if you carry it. Build aerobic capacity. Sleep enough. Drink less. Treat blood pressure and ApoB. Nothing sold as an anti-aging product has randomized evidence approaching any of these.
That ordering is not an accident, and understanding why makes the rest of this page easier to read. Second-generation methylation clocks were trained against clinical biomarkers and mortality — so anything that improves glucose control, inflammation, liver function and fitness improves the score almost by construction. The clock is downstream of your health, which is exactly why chasing the number directly is the wrong strategy.
The Verdict
The levers, ranked by strength of human evidence
"Time to see change" is the interval before a matched retest is likely to show real movement rather than noise. Note the shape of the table: the top is mostly free, the bottom is expensive and unproven.
| Intervention | Evidence strength | Why it moves the number | Time to see change | Practical note |
|---|---|---|---|---|
| Stopping smoking | Strong | Smoking exposure is weighted directly into GrimAge, and smoking is the largest single modifiable mortality risk | 12–24 months | Nicotine replacement, varenicline, and structured programs all raise quit rates |
| Correcting insulin resistance and high blood glucose | Strong | HbA1c and glucose feed second-generation clocks directly, and metabolic disease drives most age-related conditions | 3–12 months | Fasting insulin and HOMA-IR move first, well before HbA1c |
| Losing visceral fat if it is elevated | Strong for health, moderate for clock movement | Visceral fat drives inflammation, insulin resistance, and liver fat at once | 6–12 months | Waist-to-height ratio under 0.5 is a usable target |
| Aerobic training | Strong for mortality, moderate for clock movement | Cardiorespiratory fitness is among the strongest mortality predictors measured | 6–12 months | 150+ minutes weekly of moderate activity is the floor, not the goal |
| Resistance training and adequate protein | Strong for function, indirect for clocks | Preserves lean mass, bone density, and insulin sensitivity | 6–12 months | Two sessions weekly across major movement patterns |
| Treating hypertension and high ApoB | Strong for outcomes, indirect for clocks | These drive cardiovascular events regardless of what a clock reports | 3–6 months | The outcome benefit is established even if the score barely moves |
| Sleeping 7–9 hours consistently | Moderate | Short sleep raises inflammatory markers and glucose, both of which feed composite scores | 1–3 months | Consistency of timing matters alongside duration |
| Reducing alcohol | Moderate | Improves liver markers, inflammation, blood pressure and sleep architecture together | 2–6 months | The effect compounds because it moves four inputs at once |
| Vaccination and avoiding repeated infection | Moderate | Chronic and repeated immune activation shifts inflammatory markers and cell composition | Ongoing | Also removes a major source of test-to-test noise |
| Sustained caloric restriction | Moderate, from one randomized trial | CALERIE found a small but statistically real slowing of DunedinPACE over two years | 12–24 months | Effect size was a few percent of pace, not years erased |
| Supplement stacks marketed for epigenetic age | Weak | Few randomized trials, small samples, short follow-up, varied clocks | Unproven | NAD+ precursors raise blood NAD+ levels; healthspan benefit in humans is not established |
| Clinic protocols such as plasma exchange | Weak to emerging | Early human data, high cost, no hard outcome trials | Unproven | Risk profile is real and should be discussed with a physician |
What the evidence supports, and where marketing goes further
Three claims sit in this category and they carry very different weights. Separating them is the single most useful thing a reader can do here.
- Well supported. These behaviors lower disease incidence and mortality. This evidence predates biological age testing by decades and does not depend on it in any way.
- Partly supported. These behaviors associate with younger-looking clock readings in observational data. Association is not causation, and observational designs cannot exclude a third factor driving both. Randomized trials showing an intervention shifts a clock are few, small, short, and use different clocks, which makes them hard to pool.
- Not established. That lowering the clock reading itself causes better outcomes. The clock is a surrogate marker. Medicine has a long record of surrogates that predicted an outcome and then failed to deliver it when treated as a target. Until an intervention trial measures hard outcomes rather than the marker, the number is a progress signal, not a goal.
The most rigorous evidence available is CALERIE, a randomized trial of sustained caloric restriction, which found a small but statistically real slowing of DunedinPACE over two years. A few percent of pace, from a supervised two-year intervention in a controlled trial, is the correct scale to calibrate against. Observational work on smoking cessation shows larger apparent effects on GrimAge, though that partly reflects smoking status being weighted directly into that clock rather than a general reversal effect.
A 12-month protocol that produces real information
The failure mode most people fall into is testing frequently and changing everything at once, which guarantees an uninterpretable result. This sequence is built so that the fast-responding markers carry the feedback loop while the clock runs on its own slower schedule.
| When | What to do | Why | How to read it |
|---|---|---|---|
| Weeks 0–6 | Two baseline samples 4–6 weeks apart, same vendor, matched conditions | A single first reading is usually taken in an unrepresentative week | Average the two and treat that as your starting point |
| Weeks 0–2 | Full blood panel: fasting insulin, HbA1c, ApoB, hs-CRP, lipids, liver enzymes, blood pressure | These name specific problems the composite score cannot | Anything abnormal here outranks the clock as a priority |
| Weeks 0–4 | Function baselines: VO2 max or an estimate, grip strength, waist-to-height ratio | Fitness and body composition predict outcomes strongly and respond to training | Set targets rather than tracking a summary number |
| Months 1–9 | Run the top three levers that apply to you, and only those | Changing everything at once means you learn nothing about what worked | Track adherence weekly, not the clock |
| Months 3, 6, 9 | Repeat blood markers only | Fasting insulin and hs-CRP respond in 8–12 weeks; the clock does not | This is the feedback loop that keeps you going |
| Month 12 | Repeat the methylation test under matched conditions | A year is the shortest interval where change plausibly exceeds noise | Compare against your averaged baseline, not your worst reading |
Two design choices in that table are deliberate. First, blood markers carry the short loop because fasting insulin, hs-CRP, and triglyceride-to-HDL ratio respond within 8 to 12 weeks and cost a fraction of a methylation test to repeat. Second, running only two or three levers at once means that if something moves, you know roughly what moved it. Changing diet, training, sleep, alcohol, and three supplements simultaneously produces a result you cannot attribute to anything.
What to measure alongside the clock
These are the markers that name a problem and a fix, which a composite score cannot do.
- Fasting insulin and HOMA-IR. The earliest routine warning of insulin resistance, often rising years before fasting glucose becomes abnormal. Responds in 8–12 weeks.
- HbA1c. Reflects roughly 90 days of average glucose, so allow at least three to four months before expecting movement. Note that it reads falsely low in anemia or with a shortened red cell lifespan, and can read falsely high in iron deficiency.
- ApoB. The measure most closely tied to atherosclerotic risk, and more informative than LDL cholesterol alone. It is treatable, which makes it more useful than any score.
- hs-CRP. Systemic inflammation. Highly responsive to acute illness, so interpret a single elevated value cautiously and repeat it.
- Blood pressure. Measured properly at home across several days, not once in a clinic. Among the highest-yield numbers in all of preventive medicine.
- VO2 max and grip strength. Functional capacity predicts mortality strongly and improves with training on a timescale you can feel.
- Waist-to-height ratio. A free proxy for visceral fat. Under 0.5 is a usable target.
Safety and contraindications
Most of what works here is low risk. The part that is not low risk is the part being marketed hardest.
- Prescription drugs used off-label for aging. Rapamycin and metformin are being studied for this purpose and neither is established for healthy people. Rapamycin is an immunosuppressant with a real side-effect profile. Neither belongs outside a trial or specialist supervision.
- Senolytics. Human data is early and mostly in specific disease contexts. Self-administered protocols are experimentation without monitoring.
- Plasma exchange and similar clinic procedures. Invasive, expensive, and without hard outcome trials for this indication.
- High-dose supplement stacks. Dose-related harm is real for several common ingredients, and supplement–drug interactions are common. Anyone on anticoagulants, thyroid medication, or chemotherapy should clear additions with a clinician.
- Aggressive caloric restriction. Not appropriate for anyone underweight, pregnant, adolescent, older and frail, or with a history of disordered eating. Muscle and bone loss are real risks when restriction is not paired with protein and resistance training.
- Starting hard training from sedentary. Anyone with known cardiovascular disease, uncontrolled hypertension, or new exertional symptoms should be evaluated before starting an intense program.
Who has headroom, and who does not
The realistic ceiling depends entirely on where you start, and this is rarely stated. Someone who smokes, has untreated prediabetes, carries substantial visceral fat, and does no structured exercise has several years of plausible improvement available across two to four years of sustained work. Almost all of it comes from the top four rows of the table above.
Someone already lean, non-smoking, aerobically fit, and metabolically healthy has very little headroom, and should expect their number to move within the noise band regardless of what they do. That reader gets more from measurements that produce a specific target — a coronary artery calcium score, an ApoB level, a DEXA scan, a properly conducted VO2 max test — than from another composite. There is nothing left for the clock to detect, and no intervention list can change that.
Next
- What is biological age — and why tests disagree
- Elysium Index review
- TruDiagnostic review
- Biological age hub — the four methodologies compared
Related
- Biomarker guides — the markers that respond fastest
- Average biological age by decade — why the gap is the number, not the age
- Does stress accelerate aging — the evidence once behaviour is accounted for
- Normal vs optimal ranges
- Reversal vs management — fixing the metabolic drivers behind these scores
- Supplement guides — what the evidence supports and what it does not
Frequently Asked Questions
Can you actually lower your biological age?
You can lower the reading a test produces, and you can improve the underlying health that the reading is standing in for. Those are two different achievements, and only the second is clearly worth pursuing. Randomized evidence that any intervention shifts a methylation clock is limited to small, short studies plus one rigorous caloric-restriction trial that found a change of a few percent in pace of aging over two years. Evidence that the interventions themselves improve health and lower mortality is far stronger and much older. Pursue the health outcome; treat the number as a rough progress indicator.
What lowers biological age the most?
The largest, least glamorous levers, in roughly this order: stopping smoking, correcting insulin resistance and elevated blood glucose, losing visceral fat if it is elevated, and building cardiorespiratory fitness. Second-generation clocks were trained against clinical biomarkers, so anything that improves glucose control, inflammation, liver function and fitness improves the score almost by construction. Nothing sold as an anti-aging product outranks these, and no supplement has randomized evidence approaching them.
How much change is realistic?
Modest, and slower than marketing suggests. The most rigorous randomized evidence, from the CALERIE caloric-restriction trial, found a change on the order of a few percent in pace of aging over two supervised years. Larger apparent shifts in observational reports and personal case studies usually reflect a baseline taken during illness, sleep deprivation, or acute inflammation compared against a later reading taken under better conditions. Someone who smokes, has untreated prediabetes, and carries substantial visceral fat has real headroom. Someone already lean, fit, and metabolically healthy has very little, and should expect the number to barely move.
Do NAD+ precursors like NR or NMN lower biological age?
Human trials show that nicotinamide riboside raises blood NAD+ levels reliably and is generally well tolerated at studied doses. What has not been established is that raising NAD+ slows aging, extends healthspan, or lowers a methylation clock reading in humans. The trials that exist are mostly short, small, and measure biochemical intermediates rather than health outcomes. This is a fair summary of an active research area rather than a dismissal — the mechanism is plausible and the outcome evidence is not there yet. Budget accordingly.
How often should I retest to see if it is working?
No more than once every 9 to 12 months for the clock itself, and always under matched conditions: same vendor, same time of day, same fasting state, no testing within two to four weeks of illness, vaccination, a hard training block, or a stretch of poor sleep. Test–retest variation of a few years is common, which means quarterly testing mostly measures noise. Use blood markers for the short feedback loop instead — fasting insulin, hs-CRP, and triglyceride-to-HDL ratio all respond within 8 to 12 weeks and cost far less to repeat.
Why did my biological age go up even though I was doing everything right?
Check the confounders before concluding anything. Blood cell composition shifts after an infection or a vaccination and changes the methylation readout on its own. Acute inflammation from illness, an unusually hard training block, or a stretch of poor sleep moves second-generation clocks. Switching vendors resets your baseline entirely, because different platforms and normalization pipelines produce non-comparable numbers. And ordinary test–retest variation covers a range of a few years without anything happening at all. A single unexpected result is rarely the signal it appears to be.
Is it safe to take rapamycin, senolytics, or do plasma exchange for this?
These are not established interventions for healthy people, and none has outcome evidence supporting routine use for lowering biological age. Rapamycin is an immunosuppressant with real side effects and should only be considered inside a trial or under specialist supervision. Senolytic protocols are being studied for specific conditions and the human data is early. Plasma exchange is an invasive procedure with a defined risk profile and no hard outcome trials for this indication. Anyone with a chronic condition, on medication, or pregnant should not be experimenting here without a physician involved.
If I only do one thing, what should it be?
Whichever of the big four applies to you, in this order: stop smoking if you smoke; fix insulin resistance if fasting insulin or HbA1c is elevated; lose visceral fat if your waist-to-height ratio is above 0.5; build aerobic capacity if it is low. If none applies, the highest-value next step is not a supplement — it is measuring what you have not measured, particularly ApoB, blood pressure, and VO2 max, each of which produces a specific, treatable target.